2026 University of Illinois Cancer Center
Winter CME Series
January 14, 2026 – GENERAL ONCOLOGY
January 21, 2026 – Women's HEALTH
January 28, 2026 – HEMATOLOGIC MALIGNANCIES
THE LIVE STREAM LOGIN INSTRUCTIONS WILL BE SENT ON TUESDAY BEFORE EACH OF THE SESSIONS. YOU MUST BE REGISTERED TO RECEIVE THE LOGIN INSTRUCTIONS.
FULTON LABS
400 N ABERDEEN, 16th FLOOR
FULTON MARKET
CHICAGO, IL
Organized By:
Hosted By:
Conference Information
The sessions will be recorded and will be posted online for on-demand access within 60 to 90 days following the live events.
THE DETAILS FOR EACH SESSION
ARE AVAILABLE BELOW BY SESSION DATE.
REGISTRATION FEES PER SESSION:
INDUSTRY = $200
MD/DO = $100
APP = $50
STUDENTS/FELLOWS = $0.00
UNIVERSITY OF ILLINOIS CHICAGO STAFF, FACULTY AND AFFILIATES = $0.00
Registration
- Educational Presentations on hematologic malignancies
- Late-breaking and novel treatment recommendations and findings incorporated into each session
- Faculty panel discussions with audience participation
- Interaction with Course Chairs & Faculty Presenters
- Complimentary networking event from 6-7pm for all Attendees, Faculty, and invited sponsors and exhibitors
- Catch up with Colleagues and Friends
- Exhibits with over 15 Industry Organizations Represented
- Non-CME Ancillary Event Sponsored by during the Mid-Session Break
- Registration Bag with Printed Program Materials, Bag Inserts and Exciting Swag
- Great local food
- Free Parking with a validated ticket from the Conference Onsite Staff
DETAILS FOR SESSION 1: JANUARY 14, 2026 – General Oncology
Educational Goal
learning Objectives
Target Audience
Preliminary Agenda
Lung, GI, GU, Neuro Oncology
Session 1 Materials
• PROGRAM HANDOUT
• SIGN IN SHEET
• PRODUCT THEATER SIGN IN SHEET
• PRE TEST
• POST TEST, EVAL, CLAIM CREDIT - This will be shared via email onsite.
Series Chair
VK Gadi, MD, PhD
Deputy Director,
University of Illinois Cancer Center
Professor and Director, Medical Oncology
UIC Department of Medicine
University of Illinois Cancer Center
Chicago, IL
Session Chair
Stefania Maraka, MD
Assistant Professor
Department of Neurology and Rehabilitation
UI Health
Chicago, IL
DETAILS FOR SESSION 2: JANUARY 21, 2026 – Woman's Health
Educational Goal
learning Objectives
Target Audience
Agenda
Gyn Onc, Late Stage BC, Early Stage BC, Rad Oncology
Session 2 Materials
• GUIDEBOOK
• SIGN-IN SHEET
• PRE-TEST
• POST TEST, EVAL, AND CLAIM CREDIT - This will be shared onsite and via email at the end of the session
Series Chair
VK Gadi, MD, PhD
Deputy Director,
University of Illinois Cancer Center
Professor and Director, Medical Oncology
UIC Department of Medicine
University of Illinois Cancer Center
Chicago, IL
Session Chair
Christina Son, MD
Associate Professor
Department of Radiation & Cellular Oncology
UI Health
Chicago, IL
DETAILS FOR SESSION 3: JANUARY 28, 2026 – Hematologic Malignancies
Educational Goal
learning Objectives
Target Audience
Agenda
TBD
Session 3 Materials
• GUIDEBOOK
• SIGN-IN SHEET
• PRE-TEST
• POST TEST, EVAL AND CLAIM CREDIT - This will be shared onsite and via email at the end of the session
Series Chair
VK Gadi, MD, PhD
Deputy Director,
University of Illinois Cancer Center
Professor and Director, Medical Oncology
UIC Department of Medicine
University of Illinois Cancer Center
Chicago, IL
Session Chair
Ameet R. Kini, MD, PhD
Visiting Professor of Clinical Pathology
Department of Pathology
UI Health
Chicago, IL
Support Opportunities
Click HERE for the sponsorship opportunity details.
Click HERE for Exhibitor Information
To complete the application, please go to: https://cmersvp.com/uicmew/uicmew-2026-exhibitor-payment-form/
LOCATION
FULTON LABS
400 N. ABERDEEN
Chicago, IL 60642
https://fultonlabs.com/400-n-aberdeen/
Parking and Public Transit Information
- 7 minutes to I-90/94, 6 minutes to I-290
- 2 blocks to #65 bus on Grand
- 9-minute walk to Pink/Green line Morgan 'L' station
- 10-minute walk to Blue line Grand 'L' station (or via #65 bus)
- Future Fulton Market Metra stop only 4-5 blocks from Fulton Labs
The University of Illinois Cancer Center Winter CME Series is currently being planned and will be a CME event.
Educational Goal
Target Audience
learning Objectives
After participating in these activities, learners will be better able to:
- Participants will be able to evaluate the efficacy and safety of using PARP inhibitors in managing HRR-mutated metastatic prostate cancer, including potential side effects and monitoring parameters.
- Participants will be able to review the latest guidelines and recommendations for peri-operative therapy in localized rectal cancer.
- Participants will identify the role and significance of biomarkers in early and advanced-stage non-small
cell lung cancer
Agenda
Day 1 – Wednesday, January 24, 2024
1:00 – 2:00pm – Registration, Exhibits, Ancillary Events
2:00 – 2:05pm – Introduction
2:05 – 2:50pm – Shifting Paradigms in the Treatment of Metastatic Prostate Cancer
2:50 – 3:35pm – The Evolving Landscape of Peri-operative Therapy for Localized Rectal Cancer: What Clinicians Need to Know
3:35 – 4:35pm – Break, Exhibits, Ancillary Events
4:35 – 5:20pm – Navigating Neoadjuvant Options: Current Updates in the Perioperative Treatment for Early-Stage Lung Cancer
5:20 – 6:05pm – Precision Oncology: Leveraging Biomarkers for First-Line Treatment in NSCLC
6:05 – 7:00pm – Exhibits, Ancillary Events
Session 1 Materials
Series Course Chair
VK Gadi, MD, PhD
Deputy Director, University of Illinois Cancer Center
Professor and Director, Medical Oncology, UIC Department of Medicine
University of Illinois Cancer Center
Chicago, IL
Co-Chair
Faculty
Educational Goal
Target Audience
The target audience for this conference is medical oncologists, hematologists, pathologists, oncology
nurses, fellows, residents, advanced practice providers, family practitioners, primary care practitioners,
allied health professionals, and other providers interested in the care of patients with cancer.
learning Objectives
After participating in these activities, learners will be better able to:
- Discuss current and future roles of newly approved targeted therapies in all breast cancer subtypes
- Understand the side effects of practice-changing novel therapies and their integration into community practice
- Discuss emerging strategies for patients with platinum-resistant ovarian cancer
Agenda
Day 2 – Wednesday, January 31, 2024
1:00 - 2:00pm – Registration, Exhibits, Ancillary Events
2:00 – 2:05pm – Introduction
2:05 – 2:50pm – Recent Updates in Early-Stage Breast Cancer
2:50 – 3:35pm – Metastatic Breast Cancer Overview: Come Learn all the new Study Acronyms!
3:35 – 4:35pm – Break, Exhibits, Ancillary Events
4:35 – 5:20pm – Update in Genetics for the Oncologist
5:20 – 6:05pm – Incorporating Immunotherapy and other New Agents in Endometrial and Cervical Cancers
6:05 – 7:00pm – Exhibits, Ancillary Events
Series Course Chair
VK Gadi, MD, PhD
Deputy Director, University of Illinois Cancer Center
Professor and Director, Medical Oncology, UIC Department of Medicine
University of Illinois Cancer Center
Chicago, IL
Co-Chair
Faculty
Kent Hoskins, MD
Eileen Lindsey Heidrick Professor in Oncology and Professor of Medicine
Department of Medicine, Division of Hematology/Oncology
University of Illinois Cancer Center
Chicago, IL
Educational Goal
Target Audience
learning Objectives
After participating in these activities, learners will be better able to:
- Discuss the optimal strategies for the use of CAR T Cell and bispecific T-cell engagers in Diffuse Large B Cell Lymphoma
- Explain how to optimize treatment selection in Multiple Myeloma, including the use of bispecific T- Cell engagers
- Identify novel treatment approaches in Acute Lymphoblastic and Acute Myeloid Leukemia
Agenda
Day 3 – Wednesday, February 7, 2024
1:00 – 2:00pm – Registration, Exhibits, Ancillary Events
2:00 – 2:05pm - Introduction
2:05 – 2:50pm – How to best incorporate CAR T and new targeted immunotherapy in DLBCL
2:50 – 3:35pm – Management of newly diagnosed and relapsed Multiple Myeloma in 2024
3:35 – 4:35pm – Break, Exhibits, Ancillary Events
4:35 – 5:20pm – Emerging induction and consolidation regimens in Acute Lymphoblastic Leukemia
5:20 – 6:05pm – Latest advancements in targeted therapy in Acute Myeloid Leukemia
6:05 – 7:00pm – Exhibits, Ancillary Events
Series Course Chair
VK Gadi, MD, PhD
Deputy Director, University of Illinois Cancer Center
Professor and Director, Medical Oncology, UIC Department of Medicine
University of Illinois Cancer Center
Chicago, IL
Co-Chair
Faculty
Support Opportunities
Click HERE for the sponsorship opportunity details.
If you are interested in a Product Theater or Onsite Meeting Space, please email
nicole@mymededco.com to discuss availability before you complete the application.
To complete the application, please go to: https://cmersvp.com/exhibit-processing-form/
For custom sponsorship packages, please get in touch with Nicole @ 815-861-9069 /
nicole@mymededco.com
Click HERE to view the Agenda
Exhibitor Information - Logistics - Click HERE
UICMEW 4th Floor Diagram - Click HERE
HOW TO GET TO VENUE SIX10
Parking and Public Transit Information
Parking and Public Transit Map
PARKING WILL BE COMPLIMENTARY ONLY IN THE GARAGE LOCATION LISTED IN THE PARKING AND PUBLIC TRANSIT INFORMATION.
THE CONFERENCE ORGANIZERS WILL VALIDATE YOUR PARKING
Accreditation
This activity is jointly provided by Global Education Group and myMedEd.
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and myMedEd, Inc. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates these live activities for a maximum of 3.0 AMA PRA Category 1 Credits™ each. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.
Instructions for Obtaining Credit
In order to receive credit, participants must attend the activity in its entirety. Participants must also score at least a
70% on the post-test and submit it, along with the credit application and evaluation form. Statements of credit will
be emailed within 4 to 6 weeks following the program.
System Requirement
PC
1.4 GHz Intel Pentium 4 or faster processor (or equivalent)
Windows 10, 8.1 (32-bit/64-bit), Windows 7 (32-bit/64-bit)
512 MB of RAM (1 GB recommended)
Microsoft Internet Explorer 11 or later, Windows Edge browser, Mozilla Firefox, and Google Chrome
For HTML Client – Google Chrome (v70.0 & above), Mozilla
Firefox (v65.0 & above), and Edge (v42.0 & above)
MAC
1.83 GHz Intel Core Duo or faster processor
512 MB of RAM (1 GB recommended)
MAC OS X 10.12, 10.13 and 10.14
Mozilla Firefox, Apple Safari, Google Chrome
For HTML Client – Google Chrome (v70.0 & above),
Apple Safari (v12.0 & above), and Mozilla Firefox
(v65.0 & above)
Fee Information & Refund/Cancellation Policy
REGISTRATION FEES PER SESSION:
INDUSTRY = $200
MD/DO = $100
APP = $50
STUDENTS/FELLOWS = $0.00
UNIVERSITY OF ILLINOIS CHICAGO STAFF, FACULTY AND AFFILIATES = $0.00
Cancellations and refunds will be processed based on the following:
Up to 30 days prior to the conference = 100%
29 - 15 days prior to the conference = 50%
14-7 days prior to the conference = 25%
6-0 days prior to the conference = 0%
If you would like to request a refund, please email info@mymededco.com
Disclosures of Relevant Financial Relationships
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
Disclosure information coming soon...
The planners and managers at Global Education Group and MyMedEd have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and myMedEd do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Americans with Disabilities Act
Event staff will gladly assist you with any special needs (I.e., physical, dietary, etc.). Please contact myMedEd, inc. before the live event at (800) 973-0665 x2.
Organized By:
Hosted By: